Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02979626 · ClinicalTrials.gov registry record
Evaluation of Moderate to Severe Influenza Outcomes in Children
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 1,478
- Enrollment target
NCT02979626: Completed study, sponsored by University of Colorado, Denver.
NCT02979626 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 1,478 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02979626 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 1,478 participants
- Enrollment target
Study Summary
The purpose of this study was to determine whether moderate-severe endpoints (including high fever, lower respiratory tract disease, acute otitis media, or serious extra-pulmonary complications) were predictive of hospitalization, intensive care admission, antibiotic use and other complications in children under 8 years of age.
Primary Outcome
Hospitalization within 14 days of influenza infection diagnosis
Interventions
- PROCEDURE Respiratory nasal swab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,478 participants |
| Start Date | 2017-01-30 |
| Est. Completion | 2018-05-05 |
What the finished NCT02979626 record still lists
NCT02979626 is an observational study that tracks outcomes without assigning an intervention. Its 1,478 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Respiratory nasal swab is the first listed.
NCT02979626 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02979626 about?
NCT02979626 is a clinical study titled "Evaluation of Moderate to Severe Influenza Outcomes in Children". The purpose of this study was to determine whether moderate-severe endpoints (including high fever, lower respiratory tract disease, acute otitis media, or serious extra-pulmonary complications) were predictive of hospitalization, intensive care admission, antibiotic use and other complications in c...
What is the current status of trial NCT02979626?
This trial is currently completed. The enrollment target is 1,478 participants. The study started on 2017-01-30. Estimated completion is 2018-05-05.
What interventions are being tested in trial NCT02979626?
The interventions under investigation include: Respiratory nasal swab (PROCEDURE).
Who is sponsoring clinical trial NCT02979626?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05869552 · 1,485 participants · NA
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI